Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 3 clinical trials
Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy

Myelosuppressive Chemotherapy which is likely to cause clinically significant febrile neutropenia.

  • 0 views
  • 25 Jan, 2021
An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca

This is a multicenter, prospective, observational cohort registry in subjects receiving myelosuppressive chemotherapy for a non-myeloid malignancy who are considered to be at high risk for

  • 0 views
  • 27 Jan, 2021
  • 3 locations
The Oronasal Microbiota in Pediatric Oncology Patients

, including those patients receiving myelosuppressive chemotherapy or undergoing hematopoietic stem cell transplantation. In these patients, organisms typically considered as commensals can become pathogenic

myeloid leukemia
stem cell transplantation
cell transplantation
leukemia
  • 28 views
  • 24 Jul, 2021
  • 1 location